Milli-Mark Anti-CD7-PE

Analysis Note

ControlPBMCs

Application

This Milli-Mark Anti-CD7-PE Antibody, clone CBC.37 is validated for use in FC for the detection of CD7.

Research Sub CategoryImmunoglobulins & Immunology

Research CategoryInflammation & Immunology

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

The CD7 antigen is a membrane-bound 40 kDa glycoprotein expressed on thymocytes, mature T cells, a large majority of natural killer cells, pluripotent hematopoietic stem cells, and progenitor cells of lymphoid and myeloid cells (Bowen, 2002 and 1997). CD7 is one of the earliest T-cell-specific antigens to be expressed in lymphocytes, and the only early marker to persist throughout differentiation (Chang, 1994).

Immunogen

CEM T-cell line (ATTC CCL-199), a T-lymphoblastold cell line.

Legal Information

MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Protein A purified

Purified Mouse monoclonal IgG2b conjugated to PE in 0.05M Tris-HCl buffer with 1% BSA, Sodium Azide at 0.097% at pH 7.2.

Quality

Evaluated by flow cytometry using human PBMCs

Specificity

Antibody recognizes Human CD7 antigen.

Storage and Stability

Maintained refrigerated at 2-8°C from date of receipt. Protected from light in undiluted aliquots for 6 months from date of receipt.

Target description

40 kDa (Bowen, 2002 and 1997)